Close Menu

tuberculosis

The deal will enable PerkinElmer to grow its infectious disease testing portfolio to include latent tuberculosis detection, it said.

In PLOS this week: genomic and transcriptomic analysis of conjunctival melanoma, phylogenetic analysis of Clostridioides difficile, and more.

The researchers believe that their prototype could be the basis of a portable, point-of-care testing platform that would enable rapid testing anywhere.

The WHO and FIND are supporting NGS-based testing in low-resource settings, while a resistance testing program at New York State's Wadsworth Center has matured.

The company's CEO said that its single-molecule tethering technology has demonstrated limits of detection comparable to commercial molecular tests.

The company's Q3 sales reflect ongoing demand for COVID-19 testing products and improved customer demand in other areas of the firm's portfolio.

The option was exercised under a multiyear contract between T2 Bio and BARDA valued at a total of $69 million if all options are exercised.

In Genome Biology this week: analysis of tuberculosis samples from the 1600s, tool to detect variants affecting RNA-binding protein activity, and more.

The money will be used for research and development, building a clinical laboratory network, and seeking regulatory approval.

In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.

Pages

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.